Work

The Ongoing Debate of Who to Treat for Chronic Hepatitis C Virus

Year: 2014

Type: editorial

Abstract: Chronic hepatitis C virus (HCV) infection is a major cause of cirrhosis and hepatocellular carcinoma worldwide(1) and the leading indication for liver transplantation in the adult United States population.(2) Although the incidence of chronic HCV infection is declining, the number of deaths is projected to rise over the next decade.(3) Hence, the major reason for treating chronic HCV infection is to mitigate the morbidity and mortality associated with the infection but also to alleviate patient symptoms and to prevent person-to-person transmission. Successful eradication or virological cure is possible and a reduction in liver-related outcomes has been demonstrated in patients with advanced liver disease who achieve this desirable endpoint.(4–6)

Source: JAMA Internal Medicine

DOI: 10.1001/jamainternmed.2014.4299

Author: Marc G. Ghany

Institutions: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases